The addition of skeletal muscle relaxants to an ibuprofen regimen may not further alleviate acute low back pain or improve functioning.
Knee pain in older people may be associated with greater back pain/disability.
In community-dwelling older adults, low back pain-related disability may be associated with an increased risk for serious falls.
Joint hypermobility may not be associated with chronic low back pain or lumbar osteoarthritis.
Lumbar range of motion in individuals with chronic low back pain may be predicted by task-specific measures of pain-related fear.
Older individuals with vs without chronic low back pain may have lower skeletal muscle mass.
Mindfulness-based cognitive therapy may represent a feasible and efficacious treatment for chronic low back pain.
Tanezumab, an investigational subcutaneously-administered, non-opioid treatment, may benefit patients with moderate to severe chronic low back pain (CLBP), according to top-line results from a Phase 3 study.
A task force of regenerative medicine experts has formulated new guidelines for the safe and effective use of biologics in the management of low back pain.
Intradiscal methylene blue injection was not found to alleviate pain in patients with chronic diskogenic low back pain.